Literature DB >> 31275810

Doppler echocardiographic assessment of pulmonary artery pressure in children with sickle cell anaemia.

Moriam Omolola Lamina1, Barakat Adeola Animasahun2, Ijeoma Nnena Akinwumi2, Olisamedua Fidelis Njokanma2.   

Abstract

BACKGROUND: Pulmonary artery hypertension (PAH) is a known complication of patients with sickle cell disease (SCD). The prevalence of PAH has been reported to be high in children with SCD in developed countries. The mortality rate of patients with SCD who develop PAH is said to be 40% at 24 to 40 months after diagnosis. In Sub-Saharan Africa, particularly Nigeria, where the prevalence of SCD is high, there is a dearth of data on the prevalence of PAH in children with SCD. PAH may be a likely contributor to the unacceptably high mortality rate of children with SCD in Africa. The present study aimed to determine the pattern of pulmonary artery pressure in children with sickle cell anaemia (SCA) aged 1 to 12 years in their steady state using Doppler echocardiography in our environment.
METHODS: Analytical, comparative and cross-sectional study. It was carried out at Lagos State University Teaching Hospital (LASUTH) over a period of seven months (31st August 2015 through 31st March 2016). A total of 400 children, aged 1 to 12 years were recruited following parental consent and assent. Two hundred children with SCA in steady state and 200 age and sex matched children with haemoglobin genotype AA who served as controls were studied. All subjects and controls had Doppler echocardiography performed on them by the author. PAH was defined as a pulmonary artery systolic pressure (PASP) of ≥30 mmHg at rest derived from the tricuspid regurgitant velocity (TRV) measured from Doppler echocardiography. This corresponds with TRV value of ≥2.5 m/s.
RESULTS: The prevalence of PAH in children with SCA was 8% (n=16). None of the controls had PAH. The youngest subject with PAH was aged 2 years. The overall mean pulmonary artery pressure of children with SCA was significantly higher than that of controls (18.54±5.81 vs. 13.76±5.71 mmHg, P=0.000). The prevalence of PAH in children with SCA demonstrated an increase in trend with age.
CONCLUSIONS: The prevalence of PAH in children with SCA in steady state is high. This complication was noticed as early as the second year of life. It is recommended that all children with SCA should have periodic Doppler echocardiography for early detection of PAH.

Entities:  

Keywords:  Pulmonary artery hypertension (PAH); sickle cell anaemia (SCA); sickle cell disease (SCD)

Year:  2019        PMID: 31275810      PMCID: PMC6603495          DOI: 10.21037/cdt.2019.04.02

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  36 in total

Review 1.  Treatment of pulmonary arterial hypertension.

Authors:  Marc Humbert; Olivier Sitbon; Gérald Simonneau
Journal:  N Engl J Med       Date:  2004-09-30       Impact factor: 91.245

2.  Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography.

Authors:  Wyman W Lai; Tal Geva; Girish S Shirali; Peter C Frommelt; Richard A Humes; Michael M Brook; Ricardo H Pignatelli; Jack Rychik
Journal:  J Am Soc Echocardiogr       Date:  2006-12       Impact factor: 5.251

3.  Sickle cell anemia a molecular disease.

Authors:  L PAULING; H A ITANO
Journal:  Science       Date:  1949-11-25       Impact factor: 47.728

4.  Increased pulmonary artery pressures among adolescents with sickle cell disease.

Authors:  Mary Nell Suell; Louis I Bezold; M Fatih Okcu; Donald H Mahoney; Felix Shardonofsky; Brigitta U Mueller
Journal:  J Pediatr Hematol Oncol       Date:  2005-12       Impact factor: 1.289

Review 5.  Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.

Authors:  Elaina E Lin; Griffin P Rodgers; Mark T Gladwin
Journal:  Curr Hematol Rep       Date:  2005-03

6.  Pulmonary hypertension in sickle cell disease.

Authors:  Kenneth I Ataga; Namita Sood; Guy De Gent; Eileen Kelly; Ashley G Henderson; Susan Jones; Dell Strayhorn; Alice Lail; Susan Lieff; Eugene P Orringer
Journal:  Am J Med       Date:  2004-11-01       Impact factor: 4.965

7.  Right ventricular abnormalities in sickle cell anemia: evidence of a progressive increase in pulmonary vascular resistance.

Authors:  Naveen Qureshi; James J Joyce; Ning Qi; Ruey-Kang Chang
Journal:  J Pediatr       Date:  2006-07       Impact factor: 4.406

Review 8.  Pulmonary hypertension in sickle cell disease: relevance to children.

Authors:  Gregory J Kato; Onyinye C Onyekwere; Mark T Gladwin
Journal:  Pediatr Hematol Oncol       Date:  2007 Apr-May       Impact factor: 1.969

9.  Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.

Authors:  Steven J Ambrusko; Sriya Gunawardena; Allison Sakara; Beth Windsor; Lizabeth Lanford; Peter Michelson; Lakshmanan Krishnamurti
Journal:  Pediatr Blood Cancer       Date:  2006-12       Impact factor: 3.167

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.